VHCP Management II’s Endocyte, Inc. Common Stock ECYT Stock Holding History

VHCP Management II’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,211,302	Closed	-$74.8M	–	24
2018 Q3	$74.8M	Sell	4,211,302 -88,698	-2%	-$1.52M	19.97%	1
2018 Q2	$59.3M	Hold	4,300,000	–	–	17.76%	1
2018 Q1	$39.1M	Buy	+4,300,000	New	+$23.7M	9.43%	2

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

VHCP Management II's ECYT Position: Q4 2018 in Review

VHCP Management II sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 4,211,302 shares — an estimated $74.8M sold.

VHCP Management II first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $74.8M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

VHCP Management II reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
VHCP Management II sold 4,211,302 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $74.8M.
VHCP Management II first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
VHCP Management II's Endocyte, Inc. Common Stock position peaked at $74.8M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on VHCP Management II's 13F filing for Q4 2018, filed 13 Feb 2019.